Abstract. The aim of the present study was to elaborate the underlying pathogenesis of laryngeal squamous cell carcinoma (LSCC). Micro (mi) RNA and messenger (m) RNA expression profiling of patients with LSCC were downloaded from The Cancer Genome Atlas (TCGA) database. Differentially expressed miRNAs (DEMIs) and differentially expressed mRNAs (DEMs) were identified in LSCC compared to normal control tissues. The DEMs targeted by DEMIs were identified and the negative correlation between DEMs and DEMIs was subjected to visualization. The potential functions of DEMs targeted by DEMIs were annotated in Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) database. A total of 663 dysregulated DEMs (449 upregulated and 214 downregulated) and 33 DEMIs (24 upregulated and 8 downregulated) were identified in LSCC compared with normal controls. 502 negative correlations between DEMIs and DEMs were identified and subjected to construct interaction network. In the network, hsa-miR-486, -34c, -206 and -182 had the highest connectivity with DEMs, and respectively regulated 39, 33, 28 and 27 DEMs. DEMs targeted by DEMIs were significantly enriched in signal transduction, actin binding and extracellular region of GO terms and focal adhesion and extracellular matrix-receptor interaction of KEGG pathways. The present study may provide valuable information for understanding the potential oncogenesis mechanism in LSCC and provide the foundation work for diagnosis biomarkers and therapeutic targets for LSCC.
Introduction
Head and neck cancer (HNC) is the common and heterogeneous malignancy in the world (1) . The subtypes of anatomic neoplasm of HNC are classified as alveolar ridge, base of the tongue, buccal mucosa, floor of the mouth, hard palate, hypopharynx, larynx, lip, oral cavity, oral tongue, oropharynx and tonsil. Laryngeal squamous cell carcinoma (LSCC) is the common malignant neoplasm in the head and neck region. It is reported that the incidence rate of LSCC is 3.5-5.1/100,000 persons, and the mortality rate is 2.0-2.2/100,000 persons in 2012 worldwide (2) .
With the development of medical technology, the five-year survival rate of patients with LSCC has been improved in recent years. Nevertheless, most of LSCC patients has lost the opportunity of surgical therapy when LSCC is detected at an advanced stage with lymph node metastasis or distant metastasis (3) . Smoking, alcohol consumption, coffee and exposure to diesel exhaust fumes increase the incidence rate of LSCC (4) .
MicroRNAs (miRNAs), a group of negative regulators of gene expression of the length of 20-25 nucleotides, have also been displayed to be involved in the LSCC pathogenesis in several published articles (5) (6) (7) (8) . miR-364a-3p promotes cell growth and metastasis in LSCC by targeting PI3K/AKT signaling pathways (5) . Decreased miR-744-3p inhibits LSCC metastasis by inactivating AKT/mTOR and the nuclear factor-κB signaling cascade (6) . The expression level of miR-149 is significantly associated with survival duration of LSCC patients and lower expression of miR-149 in patients has the shorter survival time (7) . MiR-34a promoter methylation is remarkably increased in the advanced stage LSCC and contributes to the progression, metastasis and poor survival of LSCC (8) . However, the pathogenesis of LSCC and associated signaling pathway remains to be explored.
Next generation sequencing (NGS) has proven to be a powerful tool in delineating gene expression alteration throughout cancer progression. The Cancer Genome Atlas (TCGA; https://tcga-data.nci.nih.gov/tcga/) is a publicly funded project and has produced multidimensional data in the DNA, RNA and protein levels for >30 human tumors through large-scale genome sequencing (9 of LSCC through microarray analysis (10, 11) . The aberrant miRNA-mRNA crosstalk in LSCC based on RNA-sequencing retrieved from TCGA has not yet been investigated. Therefore, the aim of the present study was to determine the pathogenesis of LSCC and to investigate the differences between LSCC and non-neoplastic tissue samples at the mRNA and miRNA expression profiling based on TCGA datasets. The study may be able to provide insights into pathogenesis mechanism and pave the way for the development of novel diagnostic markers and therapeutic targets for patients with LSCC.
Materials and methods
The Cancer Genome Atlas dataset of laryngeal squamous cell carcinoma. MRNA and miRNA expression profiling of LSCC was downloaded from TCGA (https://tcga-data.nci. nih.gov/tcga/) data portal (12) . A total of 528 patients with head and neck squamous cell carcinoma (HNSC) was available in TCGA and the corresponding clinical records were downloaded. The inclusion criteria were set as follows: (1) The subtype of anatomic organ was the larynx; (2) patients without the history of other malignancy; (3) patients without neoadjuvant treatment. A total of 105 patients with LSCC were included into the study. Level 3 mRNA and miRNA datasets of LSCC patients were generated from UNC IlluminaHiseq_ RNASeqV2 and BCGSC IlluminaHiSeq-miRNASeq, respectively.
Screening of differentially expressed mRNAs and miRNAs in LSCC. The mRNA/miRNA expression level was demonstrated as reads per million mRNA/miRNA mapped data. The differentially expressed mRNAs (DEMs) and differentially expressed miRNAs (DEMIs) between LSCC and normal samples were screened by using DESeq2 repackage in R language (13, 14) . P<0.001 and |log 2 (Fold change)|>2 were set as cutoffs.
Heat map analysis. In order to assess the similarity of gene expression patterns between LSCC and normal tissues, the DEMs and DEMIs were subjected to two-way hierarchical clustering analysis. The heat map was drawn by the 'pheatmap' package in R language (15) . A dot represented the expression level of a dysregulated DEM/DEMIs in a sample of LSCC/normal tissues.
Prediction of targeted DEMs of DEM Is. Ta rget mRNAs were predicted for DEMs by using miRWalk2 (http://zmf.umm.uni-heidelberg.de/apps/zmf/mirwalk2/) database (16) , in which the interaction between miRNAs and mRNAs is validated by experimental methods, such as western blotting, luciferase reporter gene assays and reverse transcription-quantitative polymerase chain reaction. miRNAs frequently negatively regulate the expression of the targeted mRNA. In the current work, negatively regulatory miRNA-mRNA pairs were screened. Putative targets of DEMIs were predicted by six bioinformatics algorithms covering RNA22 version 2.0 (https://cm.jefferson.edu/rna22v2.0/), miRanda-mirSVR (http://www.microrna.org/), miRDB (http://mirdb.org/miRDB/), miRWalk (http://www.umm. uni-heidelberg.de/apps/zmf/mirwalk/index.html), PICTAR2 (http://pictar.mdc-berlin.de/) and TargetScan version 6.2 (http://www.targetscan.org/). The predictive genes, synchronously retrieved by >4 algorithms in miRWalk2.0 database, were selected to compare with the identified DEMs in LSCC and the overlapped genes were considered as the target genes of DEMs.
Construction of miRNA-mRNA regulatory network. Identified DEMI-DEM regulatory pairs were visualized by Cytoscape software (http://cytoscape.org) (17) . In the regulatory network, a circular node represented the mRNA and a rectangle node represents the miRNA. The line indicated the association between DEMI and DEM. Red color represented upregulation and green color represented down-regulation.
Functional annotation of DEMs in LSCC.
Gene Ontology (GO) terms and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway were commonly used to predict the potential functions of DEMs. The functional annotation including biological process, molecular function, cellular component and pathway of DEMs was mapped by using GeneCoDis3 (http://genecodis.cnb.csic.es/analysis) (18). FDR<0.05 was set as the cutoff of GO terms and KEGG pathway (19) .
Results

Differentially expressed mRNAs in LSCC.
In the present study, level 3 mRNA expression data were downloaded from TCGA data portal (Table I) . Differentially expressed analysis was performed between LSCC and normal control samples. Finally, 663 mRNAs were identified as significantly differentially expressed under the cutoff of P<0.001 and |log2FC|>2, with 449 up-regulated and 214 downregulated mRNAs. As Table II presents, LAMA1 was the most significantly upregulated DEM in LSCC, with 116-fold upregulation; and KRT4 was the most significantly downregulated DEM in LSCC, with ~85-fold downregulation.
Differentially expressed miRNAs in LSCC.
Level 3 miRNA expression data were downloaded as well as from TCGA data portal (Table I) . Differentially expressed miRNAs (DEMIs) were identified between LSCC and normal control samples. A total of 33 DEMIs were identified as the threshold of P<0.001 and |log2FC|>2, consisting of 25 up-regulated DEMIs and 8 down-regulated DEMIs. Hierarchical clustering analysis displayed that the expression pattern of 33 DEMIs were discrimination between LSCC and control tissues (Fig. 1 ). As Table III indicates, hsa-miR-105-1 and hsa-miR-105-2 most significantly upregulated DEMIs in LSCC and hsa-miR-1-2 was significantly downregulated DEMI in LSCC.
Construction of the miRNA-mRNA network. Target genes of 33 DEMIs, predicted using the miRWalk2 database, were overlapped with the DEMs in LSCC. Target genes with significantly differential expression were deemed to the target DEMs of DEMIs. The identified reverse association between DEMs and DEMIs was visualized by Cytoscape software. A total of 502 DEMs-DEMIs pairs were subjected to construct the regulatory network. As Fig. 2 reveals, the networks were composed of 245 nodes covering 218 DEMs. In Fig. 2A , the up-regulated DEMIs/downregulated DEMs interaction network included in 142 nodes and 347 edges. hsa-miR-34c and hsa-miR-182 had the highest connectivity for DEMs and negatively interacted with 33 and 27 DEMs, respectively. In Fig. 2B , the down-regulated DEMIs/upregulated DEMs interaction network included in 103 nodes and 155 edges, hsa-miR-486 and hsa-miR-206 had the highest connectivity for DEMs and negatively interacted with 39 and 28 DEMs, respectively.
GO terms annotation of DEMs targeted by DEMIs in LSCC.
In order to predict the 218 DEMs targeted by DEMIs in LSCC, the GO term was annotated. The threshold of biological process, molecular function and cellular component terms of GO was set as FDR<0.05. As Table IV presents, multicellular organismal development (FDR=6.26x10 -5 ), blood coagulation (FDR= 6.84x10 -4 ) and regulation of proteolysis (FDR= 8.09x10
-4 ) were the most significant enrichment of biological process; actin binding (FDR=4.30x10 -9 ), protein KEGG signaling pathway enrichment. KEGG enrichment analysis was performed to understand the signaling pathways of DEMs involved in LSCC. A total of 214 out of 218 DEMs targeted by DEMIs in LSCC were significantly enriched in 13 signaling pathways, including focal adhesion (hsa04510), extracellular matrix (ECM)-receptor interaction (hsa04512), mTOR signaling pathway (hsa04150) and cytokine-cytokine receptor interaction (hsa04060), as Table V indicates.
Discussion
In order to improve understanding of LSCC, the mRNA and miRNA expression profiling of LSCC, derived from TCGA database, was subjected to integrate analysis and miRNA-mRNA crosstalk analysis in the current study.
Zhang et al (20) obtains the miRNA and mRNA expression profiling through high-throughput from 10 LSCC samples and 2 healthy samples and construct the miRNA-mRNA crosstalk in LSCC. In the published paper (20) , miR-182, miR-183 and miR-96 are identified as significantly upregulated in LSCC, which is consistent with the present analysis. Whereas, miR-1301, miR-184 and miR-224 are dysregulated in LSCC based on the analysis by Zhang et al (20) , but those miRNAs are not dysregulated in LSCC in our work. The discrimination between the results of Zhang et al (20) and the present study may be attributed to the different LSCC samples for research. On one hand, 12 experssion profiles were subjected to bioinformatics analysis in the study by Zhang et al (20) , whereas in the present study, 114 profiles were analyzed. On the other hand, LSCC samples in the study by Zhang et al (20) were obtained from China, whereas the samples in the present paper were derived from America and Asia, according to TCGA database. hsa-miR-486 reported the highest connectivity with target genes and negatively regulated 39 DEMs expression in the regulatory network, such as COL4A2, DGKG, PGF, MARCKSL1, CXCL14 and KLHDC7B. These protein-coding genes were significantly up-regulated in LSCC and enriched in 12 signaling pathways (Table V) , covering focal adhesion, ECM-receptor interaction, mTOR signaling pathway and cytokine-cytokine receptor interaction. miR-486 functions as a tumor suppressor in several types of tumor covering colorectal cancer (CRC), papillary thyroid carcinoma (PCT) and lung cancer (21) (22) (23) . miR-486-5p is downregulated in laryngeal carcinoma by microarray (24) and the roles of miR-486-5p in LSCC are unclear. miR-486-5p is downregulated in CRC tissues compared with the adjacent non-tumor tissues and the CRC mice mode presents increased miR-486-5p suppresses tumor growth and lymphangiogenesis (21) . miR-486-5p is significantly downregulated in PCT tissues and cell lines and its underexpression promotes cell proliferation and represses cell apoptosis in PTC (22) . It is reported that miR-486-5p is downregulated in lung adenocarcinoma and COL4A2 is upregulated in non-small cell lung cancer and small cell lung cancer (23, 25) . COL4A2, encodes for the collagen type IV alpha 2 chain, and is the subunit of type IV collagen, which is the major structural component of basement membranes. Abnormally expressed type IV collagen is correlated to tumor spreading and migration (26) . Upregulation of COL4A2 is involved in anoikis resistance in epithelia ovarian cancer (27) . PGF, encodes the placenta growth factor, which belongs to vascular endothelial growth factor (VEGF) family of angiogenic factors. The VEGF family serves key roles in tumor angiogenesis. It is reported that PGF is over expressed in head and neck squamous cell carcinoma, which is involved in angiogenesis (28) . PGF is upregulated in breast cancer and the increased expression of PGF is associated with recurrence, metastasis and poor prognosis in patients with breast cancer (29) . In prostate cancer, the expression of CXCL14 is positively correlated with tumor aggressiveness (30) .
hsa-miR-34c was significantly upregulated and negatively regulated 33 DEMs in LSCC, such as PRKAA2, MYOZ3 and FNDC5. It is reported that hsa-miR-34c is significantly downregulated in various tumors and acts as a tumor suppressor in NSCLC, endometrial carcinoma (EC), nasopharyngeal carcinoma (NPC) and osteosarcoma (OS) (31) (32) (33) (34) . Increased expression of miR-34c-3p inhibits cell proliferation, migration and invasion in NSCLC by targeting eIF4E (31) . Upregulated miR-34c inhibits cell proliferation and colony formation in EC by targeting E2F3 (32) . The promoter region of miR-34c is hypermethylated and miR-34c suppresses tumor growth and metastasis in NPC by targeting MET (33) . miR-34c impedes OS metastasis and chemo-resistance by targeting Notch 1 and LEF1 (34) . As the target genes of miR-34c, MYOZ3 and FNDC5 were in the top 15 downregulated DEMs in LSCC (Table II) . FNDC5 encodes a secreted protein, named fibronectin type III domain containing 5. Serum level of FNDC5 is significantly lower in patients with breast cancer compared with healthy volunteers and it is the independent risk factor of breast cancer (35) . MYOZ3 encodes myozenin 3, which belongs to myozenin family. However, the biological functions of MYOZ3 in tumor process remain unclear. To the best of the authors' knowledge, the present study is the first to report that MYOZ3 is involved in LSCC oncogenesis. PRKAA2 encodes protein kinase AMP-activated catalytic subunit alpha 2, which belongs to the Ser/Thr protein kinase family and was significantly enriched in mTOR signaling pathway and adipocytokine signaling pathway (Table V) . Except for miR-34c, PRKAA2 was regulated by miR-105, miR-182 and miR-96. hsa-miR-1-2 and hsa-miR-105-1 were the most significantly down-and upregulated DEMI in LSCC compared with normal controls, respectively. miR-1 functions as a tumor suppressor in various cancers. miR-1 and miR-133a inhibit cell proliferation, invasion and increases cell apoptosis in bladder cancer cells by downregulation of PTMA and PNP (36) . Decreased miR-1/133a cluster promotes cell migration and invasion in lung squamous cell carcinoma by targeting coronin 1C (37) . Moreover, miR-1 is downregulated and regulates focal adhesion and ECM-receptor interaction pathways in head and neck squamous cell carcinoma (38) . miR-105 is characteristically expressed in metastatic breast cancer cells compared with non-metastatic cancer cells and over expression of miR-105 in non-metastatic cancer induces metastasis and vascular permeability (39) . Upregulation of miR-105 is correlated with gastric cancer (40) .
MMP9 encodes matrix metalloproteinase 9, which belongs to the MMP family and is involved in the breakdown of extracellular matrix in disease processes, such as tumor metastasis. MMP1, MMP3 and MMP11 were also significantly upregulated in LSCC. The expression level of MMP9 is positively correlated with lymph-node metastasis and TNM stage in LSCC (41) . In the miRNA-mRNA crosstalk, MMP9 was negatively regulated by miR-133a-1 and miR-133b. Saito et al (42) indicates that miR-133b had the lower expression in LSCC compared with controls, which is in accordance with the current analysis. miR-133a-1 was another negative regulator of MMP9. miR-1-2 and miR-133a-1 are located on 18q11.2 cluster; miR-1-1 and miR-133a-2 are located on 20q13.33 cluster. In bladder cancer, miR-1 and miR-133a are involved in tumor processes including proliferation, invasion and apoptosis (36) . The roles of miR-133a in LSCC are as yet unreported.
Focal adhesion (hsa04510) and ECM-receptor interaction (hsa04512) was the most significantly dysregulated signaling pathway in LSCC. Focal adhesion serves key roles in cell motility, proliferation and cell survival of various cancers, such as triple-negative breast cancer, endometrial cancer and pancreatic ductal adenocarcinoma (43) (44) (45) . The ECM contributes to cell morphogenesis and function. ECM participates in cell adhesion, migration, differentiation, proliferation and apoptosis through interaction with some of transmembrane molecules. ECM-receptor interactions are dysregulated in colorectal cancer, clear renal cell carcinoma and esophageal squamous cell carcinoma (46) (47) (48) . It is reported that focal adhesion and ECM-receptor interaction pathways are dysregulated in head and neck squamous cell carcinoma (38) . Based on the aforementioned, focal adhesion and ECM-receptor interactions may be involved in the tumor biology including cell growth, invasion, motility and metastasis of LSCC.
In conclusion, availably public mRNA and miRNA expression profiling of LSSC, derived from TCGA database, was subjected to bioinformatics analysis. The miRNA-mRNA crosstalk was constructed and a set of key dysregulated miRNAs and signaling pathways were identified in LSCC. The hope is that the current study may be helpful for understanding the underlying oncogenesis mechanism in LSCC and provide the foundation work for diagnosis biomarkers and therapeutic targets for LSCC.
